Choice Institutional Equities recently unveiled its list of 20 top stock recommendations, projecting an upside potential of up to 65% for investors. The brokerage firm highlighted specific companies across various sectors, including Bharat Electronics (BEL), Glenmark Pharma, Mahindra & Mahindra (M&M), and Nazara Technologies.
Brokerage's Market Outlook
Despite these optimistic individual stock calls, Choice Institutional Equities maintains a cautious stance on the broader Indian market. The firm noted that while geopolitical tensions in West Asia have eased, leading to a retreat in Brent crude prices from conflict highs, macroeconomic aftershocks are beginning to emerge. India's significant reliance on crude oil and natural gas imports means that even a stabilized Brent price of $80-90 a barrel could lead to meaningful macro impacts, including sticky inflation, potential monetary tightening, and pressure on corporate profitability and consumption.
The brokerage also pointed to a weakened macro-equity setup in recent quarters, characterized by softer demand and margin pressures. Foreign Portfolio Investor (FPI) outflows have been substantial, with approximately Rs 1.5 lakh crore flowing out in FY27TD, following Rs 3.1 lakh crore in outflows during FY25 and FY26. Elevated US yields have further reduced India's appeal for overseas capital, contributing to a depreciation of the rupee by about 6.4% over the last six months.
On valuations, Choice Equities assessed the Nifty 50 at 21.4 times trailing earnings, which, while below its five-year average, remains among the highest globally. Small-cap valuations are particularly stretched at 33.2 times trailing earnings, exceeding their five-year average.
Top Stock Recommendations
Choice Institutional Equities is currently overweight on sectors such as Defence, Hospitals, New-Age Technology, and Pharmaceuticals. The firm has identified the following as its top picks, with target prices indicating significant upside:
- Allied Blenders & Distillers Ltd (Target Price: Rs 690)
- Bharat Dynamics Ltd (Target Price: Rs 1,500)
- Bharat Electronics Ltd (Target Price: Rs 500)
- Fractal Analytics (Target Price: Rs 1,250)
- Garden Reach Shipbuilders & Engineers (Target Price: Rs 3,500)
- Glenmark Pharma (Target Price: Rs 2,590)
- Jeena Sikho (Target Price: Rs 1,000)
- Lloyds Metals & Energy (Target Price: Rs 2,075)
- Lumax Auto Technologies Ltd (Target Price: Rs 1,950)
- Mahindra & Mahindra Ltd (Target Price: Rs 4,450)
- Man Industries (Target Price: Rs 690)
- Meesho (Target Price: Rs 210)
- Narayana Hrudayalaya (Target Price: Rs 2,500)
- Nazara Technologies (Target Price: Rs 400)
- Senores Pharmaceuticals (Target Price: Rs 1,165)
- Shanti Gold (Target Price: Rs 350)
- Smartworks (Target Price: Rs 630)
- Sun Pharma (Target Price: Rs 2,300)
- Yash Highvoltage (Target Price: Rs 1,200)
- Yatharth Hospital & Trauma Care Services (Target Price: Rs 1,050)
The firm cautions that a moderation in domestic Systematic Investment Plan (SIP) flows, coupled with sustained FPI absence, weaker earnings, and premium valuations, could expose Indian equities to a sharper-than-expected correction.
Disclaimer: This article provides information for educational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.